During the past decade, Roongroj Bhidayasiri conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Roongroj Bhidayasiri" are "Botulinum Toxin" (1 trials), "Cervical Dystonia" (1 trials), "Parkinson's Disease" (1 trials) and "Quality of Life" (1 trials). Many other conditions were trialed in "Roongroj Bhidayasiri" in a lesser frequency.

Most popular intervention types in "Roongroj Bhidayasiri" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nuronox" (1 trials) and "Questionaire to assess Noctural Parkinson's Disease Symptoms" (1 trials). Other intervention names were less common.

The vast majority of trials in "Roongroj Bhidayasiri" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Roongroj Bhidayasiri". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Roongroj Bhidayasiri, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Roongroj Bhidayasiri, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".